Candesartan and Hydrochlorothiazide Clinical Trials

• Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo
  ClinicalTrials.gov Identifier: NCT00282178 - Active, not recruiting
  Hypertension; Obesity
  
• Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.
  ClinicalTrials.gov Identifier: NCT00232882 - Recruiting
  Hypertension
  
• Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
  ClinicalTrials.gov Identifier: NCT00439738 - Active, not recruiting
  Hypertension
  
• Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
  ClinicalTrials.gov Identifier: NCT00425997 - Active, not recruiting
  Hypertension
  
• Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) Trial of Cardiovascular Events in High-Risk Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00125463 - Active, not recruiting
  Hypertension; Cardiovascular Diseases
  
• Scandinavian Candesartan Acute Stroke Trial (SCAST)
  ClinicalTrials.gov Identifier: NCT00120003 - Recruiting
  Stroke
  
• Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00387517 - Active, not recruiting
  Hypertension
  
• Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00500604 - Recruiting
  Hypertension
  
• Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)
  ClinicalTrials.gov Identifier: NCT00108706 - Active, not recruiting
  Cerebrovascular Accident; Acute Stroke
  
• Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial
  ClinicalTrials.gov Identifier: NCT00139386 - Recruiting
  Hypertension; Coronary Artery Disease; Coronary Angioplasty
  
• DIabetic Retinopathy Candesartan Trials
  ClinicalTrials.gov Identifier: NCT00252694 - Active, not recruiting
  Type 2 Diabetes
  
• DIabetic Retinopathy Candesartan Trials.
  ClinicalTrials.gov Identifier: NCT00252720 - Active, not recruiting
  Type 1 Diabetes
  
• Diabetic Retinopathy Candesartan Trials
  ClinicalTrials.gov Identifier: NCT00252733 - Active, not recruiting
  Type 1 Diabetes
  
• Candesartan Effectiveness Study in Pro-BNP
  ClinicalTrials.gov Identifier: NCT00348686 - Active, not recruiting
  Hypertension; Left Ventricular Hypertrophy
  
• A Randomised, Double-Blind, Placebo-Controlled, 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension.
  ClinicalTrials.gov Identifier: NCT00153049 - Completed
  Hypertension
  
• Antihypertensive Efficacy and Safety of Candesartan/HCT 32/25 mg in Comparison With Individual Components and Placebo
  ClinicalTrials.gov Identifier: NCT00434967 - Active, not recruiting
  Hypertension
  
• Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00426478 - Active, not recruiting
  Hypertension
  
• Antihypertensive Effectiveness of the Associations of Hydrochlorothiazide and Amiloride and Hydrochlorothiazide and Enalapril
  ClinicalTrials.gov Identifier: NCT00394394 - Completed
  Hypertension
  
• A Randomized, Double-Blind, Parallel-Group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison with Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients with Mild to Modera
  ClinicalTrials.gov Identifier: NCT00133185 - Completed
  Hypertension
  
• Safety and Efficacy of Valsartan Versus Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00396656 - Active, not recruiting
  Hypertension
  
• Evaluating the Effect of Candesartan vs Placebo in Prevention of Trastuzumab-Associated Cardiotoxicity
  ClinicalTrials.gov Identifier: NCT00459771 - Recruiting
  Breast Cancer
  
• Efficacy Observational Study of Candesartan Cilexetil on Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00573742 - Recruiting
  Primary Hypertension
  
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00277472 - Active, not recruiting
  Hypertension
  
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00280540 - Active, not recruiting
  Hypertension
  
• Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
  ClinicalTrials.gov Identifier: NCT00400777 - Active, not recruiting
  Hypertension
  
• Antihypertensive Efficacy and Safety of Candesartan/HCT 32/12.5 and 32/25 mg in Comparison With Candesartan 32 mg
  ClinicalTrials.gov Identifier: NCT00383929 - Completed
  Hypertension
  
• A Clinical Study to Evaluate the Long-Term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg
  ClinicalTrials.gov Identifier: NCT00171405 - Active, not recruiting
  Hypertension
  
• A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients
  ClinicalTrials.gov Identifier: NCT00219102 - Active, not recruiting
  Hypertension; Diabetes
  
• Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide
  ClinicalTrials.gov Identifier: NCT00360178 - Completed
  Hypertension
  
• Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients
  ClinicalTrials.gov Identifier: NCT00288717 - Recruiting
  Hypertension
  
• Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing
  ClinicalTrials.gov Identifier: NCT00443612 - Recruiting
  Hypertension
  
• Effects of Antihypertensive Treatment in HIV Infected Patients: Candesartan Versus Lercanidipine
  ClinicalTrials.gov Identifier: NCT00564057 - Recruiting
  HIV Infections; Hypertension
  
• A Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Phase IV Study Comparing Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg [Micardis HCT] Versus Valsartan 160 Mg + Hydrochlorothiazide 25 Mg [Diovan HCT] Taken Orally for Eight Weeks in Patien
  ClinicalTrials.gov Identifier: NCT00168779 - Completed
  Hypertension
  
• CHANCE - Candesartan in Hypertrophic Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00430833 - Active, not recruiting
  Hypertrophic Cardiomyopathy
  
• Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
  ClinicalTrials.gov Identifier: NCT00509470 - Recruiting
  Essential Hypertension
  
• Danish Hypertension Prevention Project - DHYPP
  ClinicalTrials.gov Identifier: NCT00150631 - Active, not recruiting
  Prevent or delay development of hypertension
  
• Clinical Trial to Assess the Effects of Candesartan on the Carbohydrates Metabolism of Subjects With Dysglycemia and Abdominal Obesity."ARAMIA"
  ClinicalTrials.gov Identifier: NCT00319202 - Recruiting
  Glucose Intolerance; Obesity
  
• A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-Term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
  ClinicalTrials.gov Identifier: NCT00386607 - Active, not recruiting
  Hypertension
  
• A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00170937 - Active, not recruiting
  Metabolic Syndrome; Hypertension; Pre-Hypertension
  
• Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
  ClinicalTrials.gov Identifier: NCT00446563 - Active, not recruiting
  Hypertension; Hypertrophy, Left Ventricular
  
• Pharmacokinetic Drug Interaction Study Following co-Administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00548067 - Recruiting
  Hypertension
  
• Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months
  ClinicalTrials.gov Identifier: NCT00487123 - Recruiting
  Hypertension
  
• Candesartan in the Prevention of Relapsing Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00130975 - Completed
  Atrial Fibrillation
  
• Investigation of Vascular Relaxing Effects of Candesartan and Pioglitazone.
  ClinicalTrials.gov Identifier: NCT00154037 - Completed
  Healthy subjects
  
• The Vascular Effects of Carvedilol CR + Lisinopril Versus Lisinopril + Hydrochlorothiazide in Abdominally Obese Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00459056 - Recruiting
  Abdominal Obesity; Hypertension
  
• A Pharmacogenomic Study of Candesartan in Heart Failure
  ClinicalTrials.gov Identifier: NCT00400582 - Recruiting
  Heart Failure
  
• High Dose Candesartan Versus Quinapril for Restenosis Prophylaxis After Stent Angioplasty in Peripheral Occlusive Artery Disease.
  ClinicalTrials.gov Identifier: NCT00154050 - Completed
  occlusive arterial disease
  
• Losartan vs. Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects
  ClinicalTrials.gov Identifier: NCT00388388 - Recruiting
  Pre-Hypertension; Pre-Diabetes
  
• A Comparison of Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg With Amlodipine 10 mg + Hydrochlorothiazide 12.5 mg in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. A Prospective, Randomised, Open-Label, Blinded
  ClinicalTrials.gov Identifier: NCT00240474 - Completed
  Hypertension
  
• The Renin-Angiotensin System in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00141583 - Recruiting
  Hypertension
  
• A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00538486 - Not yet recruiting
  Hypertension; Obesity
  
• Hydrochlorothiazide (+) Losartan Potassium Vs. Amlodipine Comparative Study
  ClinicalTrials.gov Identifier: NCT00157963 - Completed
  Essential Hypertension
  
• Open-Label Trial of the Efficacy and Safety of Combination of Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg Tablets in Patients With Hypertension.
  ClinicalTrials.gov Identifier: NCT00267943 - Completed
  Hypertension
  
• Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00139698 - Completed
  Essential Hypertension
  
• NIDDM and ACE2
  ClinicalTrials.gov Identifier: NCT00192803 - Not yet recruiting
  NIDDM patients
  
• Safety and Effects of Ramipril Combined With Candesartan
  ClinicalTrials.gov Identifier: NCT00356395 - Completed
  Hypertension
  
• Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00430508 - Not yet recruiting
  Essential Hypertension
  
• Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00430950 - Not yet recruiting
  Essential Hypertension
  
• Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)
  ClinicalTrials.gov Identifier: NCT00263393 - Recruiting
  * Myocardial Infarction; Angina Pectoris; Cerebrovascular Accidents; Diabetes Mellitus
  
• An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hy
  ClinicalTrials.gov Identifier: NCT00449111 - Terminated
  Hypertension
  
• Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age
  ClinicalTrials.gov Identifier: NCT00244595 - Completed
  Hypertension
  
• TROPHY - Candesartan Cilexetil Long-Term Hypertension Prevention Trial
  ClinicalTrials.gov Identifier: NCT00227318 - Completed
  Hypertension
  
• High Doses of Candesartan Cilexetil on the Reduction of Proteinuria
  ClinicalTrials.gov Identifier: NCT00242346 - Completed
  Proteinuria
  
• Avoiding Cardiovascular Events through Combination therapy in patients with Systolic Hypertension ACCOMPLISH
  ClinicalTrials.gov Identifier: NCT00097864 - No longer recruiting
  Heart Disease
  
• Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
  ClinicalTrials.gov Identifier: NCT00171561 - Completed
  Hypertension
  
• Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
  ClinicalTrials.gov Identifier: NCT00170989 - Completed
  Hypertension
  
• Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00355589 - Completed
  Hypertension; Blood Pressure, High
  
• Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00367094 - Completed
  Hypertension
  
• Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00219037 - Completed
  Hypertension
  
• A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00241007 - Completed
  Hypertension
  
• Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension
  ClinicalTrials.gov Identifier: NCT00273299 - Completed
  Hypertension
  
• Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.
  ClinicalTrials.gov Identifier: NCT00219024 - Completed
  Hypertension
  
• A Clinical Study to Compare Long-Term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine
  ClinicalTrials.gov Identifier: NCT00294710 - Completed
  Hypertension
  
• Treatment of High Blood Pressure Using Olmesartan with Hydrochlorothiazide Compared to an ACE Inhibitor with a Calcium Channel Blocker
  ClinicalTrials.gov Identifier: NCT00185120 - Completed
  Hypertension
  
• Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00263003 - Completed
  Hypertension
  
• Angiotensin-II Blockade in Mitral Regurgitation
  ClinicalTrials.gov Identifier: NCT00014846 - Completed
  Heart Diseases; Mitral Valve Insufficiency
  
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
  ClinicalTrials.gov Identifier: NCT00095394 - Completed
  Hypertension
  
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients with Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00095550 - Completed
  Hypertension
  
• A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00386139 - Completed
  Hypertension
  
• Olmesartan as an Add-on to Amlodipine in Hypertension
  ClinicalTrials.gov Identifier: NCT00220233 - Completed
  Essential Hypertension
  
• Irbesartan in the Treatment of Hypertensive Patients with Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00110422 - Completed
  Metabolic Syndrome X; Hypertension
  
• A Randomised, Double-Blind Study Comparing a Fixed Dose Combination of Telmisartan 40 Mg Plus Hydrochlorothiazide 12.5 Mg to Telmisartan 40 Mg (Micardis®) in Patients Who Fail to Respond Adequately to Treatment with Telmisartan (Micardis®) 40 Mg
  ClinicalTrials.gov Identifier: NCT00144222 - Completed
  Hypertension
  
• Diuretics, Hypertension, and Arrhythmias Clinical Trial
  ClinicalTrials.gov Identifier: NCT00000525 - Completed
  Cardiovascular Diseases; Death, Sudden, Cardiac; Heart Arrest; Heart Diseases; Hypertension